← Database
M&A

IMAPOLE

Acquired by

EURAZEO

FRANCE Health Providers EV [100m EUR - 500m EUR] 09/2022

Target

IMAPOLE

Acquirer

EURAZEO

Context

Eurazeo has partnered with Bpifrance to complete a major investment of over �50 million in Imap�le. The consortium is taking a minority stake alongside the founding associate radiologists.

IMAPOLE, which reported an EBITDA margin of LOGIN in 2021, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 12.8x average currently observed in the Healthcare & Pharma sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Based in Lyon, ImaOne is a prominent medical imaging group. The organization is managed and owned by a group of associate radiologists, providing essential diagnostic services to the regional healthcare ecosystem. As an independent player in the medical imaging sector, the group focuses on maintaining high standards of clinical excellence while navigating the evolving regulatory landscape for medical practices in France. Its operational model relies on the expertise of its medical associates to deliver specialized imaging services, ranging from standard diagnostics to advanced medical screenings.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples Analysis

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2021
LOGIN
LOGIN
LOGIN
2020
LOGIN
LOGIN
LOGIN

Other operations with IMAPOLE

mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.